MedPath

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1891-01-01
Employees
10K
Market Cap
-
Website
http://www.medschool.wustl.edu

Pilot Study of PUFA-optimized RUTF for Severe Acute Malnutrition

Not Applicable
Completed
Conditions
Kwashiorkor
Marasmus
Interventions
Dietary Supplement: RUTF
Dietary Supplement: RUTF-P
First Posted Date
2014-02-04
Last Posted Date
2014-09-29
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
141
Registration Number
NCT02053857
Locations
🇲🇼

University of Malawi College of Medicine, Blantyre, Malawi

Tranexamic Acid Dosing in Adult Spinal Deformity Surgery

Phase 2
Completed
Conditions
Adult Spinal Deformity
Interventions
Drug: Tranexamic Acid (Cyklokapron)
First Posted Date
2014-02-03
Last Posted Date
2022-06-08
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
64
Registration Number
NCT02053363
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Prevention of Noise-induced Hearing Loss

Phase 1
Withdrawn
Conditions
Noise-induced Hearing Loss
Interventions
First Posted Date
2014-01-29
Last Posted Date
2017-11-06
Lead Sponsor
Washington University School of Medicine
Registration Number
NCT02049073
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Autologous Fecal Therapy

Phase 2
Completed
Conditions
Infectious Disease of Digestive Tract
Interventions
Biological: Autologous fecal microbiota therapy
Other: Placebo
First Posted Date
2014-01-27
Last Posted Date
2019-06-04
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
10
Registration Number
NCT02046525
Locations
🇺🇸

Washington University in St. Louis, Saint Louis, Missouri, United States

Probiotics to Promote Intestinal Health

Phase 4
Completed
Conditions
Pharmacologic Actions
Communicable Diseases
Infection
Therapeutic Uses
Anti-Infective Agents
Interventions
Dietary Supplement: Probiotic
Other: Placebo
First Posted Date
2014-01-27
Last Posted Date
2022-04-04
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
89
Registration Number
NCT02046512
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Registry for Proton Beam Radiation Therapy

Completed
Conditions
Carcinoma
First Posted Date
2014-01-20
Last Posted Date
2023-07-24
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
1243
Registration Number
NCT02040467
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

🇺🇸

Rutgers University, New Brunswick, New Jersey, United States

🇺🇸

UF Health Cancer Center at Orlando Health, Orlando, Florida, United States

and more 2 locations

Effects of Obesity and Physical Inactivity on Pregnancy Outcomes

Completed
Conditions
Sedentary
Obesity
First Posted Date
2014-01-17
Last Posted Date
2016-08-22
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
40
Registration Number
NCT02039414
Locations
🇺🇸

Washington University in St. Louis, St. Louis, Missouri, United States

Eye Patch Therapy for Central Serous Retinopathy (CSR)

Phase 1
Completed
Conditions
Central Serous Retinopathy (CSR)
Interventions
Device: Eye Patching
First Posted Date
2014-01-15
Last Posted Date
2015-06-03
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
12
Registration Number
NCT02036632
Locations
🇺🇸

Washington Universtiy School of Medicine, St Louis, Missouri, United States

Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys

Completed
Conditions
Deep Vein Thrombosis
Stroke
Respiratory Failure
Angina
Pneumonia
Gastrointestinal Bleed
Heart Attack
Cardiac Arrest
Pulmonary Embolism
Respiratory Arrest
First Posted Date
2014-01-09
Last Posted Date
2022-08-09
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
73952
Registration Number
NCT02032030
Locations
🇺🇸

Barnes-Jewish Hospital, Saint Louis, Missouri, United States

Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)

Completed
Conditions
Onchocerciasis
Lymphatic Filariasis
Soil Transmitted Helminth (STH) Infections
Interventions
Drug: Annual versus Semiannual Albendazole plus Ivermectin MDA
First Posted Date
2014-01-09
Last Posted Date
2018-05-04
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
14457
Registration Number
NCT02032043
Locations
🇨🇮

Ivory Coast National Program Against Schistosomiasis, Geohelminths and Filariasis, Abidjan, Lagune-Cocody, Côte D'Ivoire

© Copyright 2025. All Rights Reserved by MedPath